Skip to content Skip to content

Press Releases


Filter Releases
 
INCLINE VILLAGE, Nev., April 16, 2018 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will hold its annual meeting of stockholders on Friday, June 8, 2018, at 10:00 a.m. Pacific Time for all stockholders of record on May 4, 2018. The meeting will take place at the Hyatt Regency Hotel in Incli...
INCLINE VILLAGE, Nev., April 3, 2018 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that Peter Garcia, PDL's vice president and chief financial officer, will present at the H.C. Wainwright Global Life Sciences Conference next week in Monaco. The session will be webcast live and will occur on Tuesday, April 1...
INCLINE VILLAGE, Nev., March 8, 2018 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today reported financial results for the fourth quarter and year ended December 31, 2017 including: Total revenues of $68.0 million and $320.1 million for the three and twelve months ended December 31, 2017, respectively. GAAP ...
INCLINE VILLAGE, Nev., March 1, 2018 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter, year-end 2017 financial results for the period ended December 31, 2017, on Thursday March 8, 2018, after market close. PDL's management will host a conference call and webcast...
INCLINE VILLAGE, Nev., Feb. 20, 2018 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) today officially announced it will no longer pursue its proposed acquisition of Neos Therapeutics, Inc. (NASDAQ: NEOS).  While PDL's last public disclosure announced its proposal expired on November 8, 2017, PDL has maintained its interest until recently making ...
INCLINE VILLAGE, Nev., Feb. 14, 2018 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's chief executive officer, will present at the following two upcoming investor conferences: 2018 RBC Capital Markets Global Healthcare ConferenceWednesday February 21, 2018 at 9:30 a.m. ESTNew York City ...
INCLINE VILLAGE, Nev., Nov. 8, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) reiterated that its proposal to acquire Neos Therapeutics, Inc. (NASDAQ: NEOS) for $10.25 per share in cash will expire today at market close. PDL originally made public its proposal to acquire Neos on October 26, 2017 at a premium of approximately 40 percent to ...
INCLINE VILLAGE, Nev., Nov. 7, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's president and chief executive officer, will present at two investor conferences in November. Jefferies 2017 London Healthcare ConferenceWednesday, November 15, 2017, 2:40 p.m. GMTLondon, U.K. 29th...
INCLINE VILLAGE, Nev., Nov. 2, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today reported financial results for the third quarter ended September 30, 2017 including: Total revenues of $62.7 million and $252.0 million for the three and nine months ended September 30, 2017, respectively. GAAP diluted EPS...
INCLINE VILLAGE, Nev., Oct. 30, 2017 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) today issued the following statement in response to the Neos Therapeutics, Inc. ("Neos") (NASDAQ: NEOS) Board of Directors' rejection of PDL's October 26 proposal to acquire Neos for $10.25 per share in cash: "While we are not su...
INCLINE VILLAGE, Nevada, Oct. 30, 2017 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) today announced that on October 27, 2017, PDL and Depomed, Inc. ("Depomed") entered into a settlement agreement with Valeant Pharmaceuticals International, Inc. and its indirect subsidiary Valeant Pharmaceuticals Luxembourg S.à r....
INCLINE VILLAGE, Nev., Oct. 26, 2017 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) today announced that it has submitted a proposal to acquire Neos Therapeutics, Inc. ("Neos") (NASDAQ: NEOS) for $10.25 per share in cash. This all-cash transaction represents a premium of 40% to the closing price of Neos shares on Octobe...
INCLINE VILLAGE, Nev., Oct. 25, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will release its third quarter financial results for the period ended September 30, 2017, on Thursday, November 2, 2017, after market close. PDL's management will host a conference call and webcast that day a...
INCLINE VILLAGE, Nev., Sept. 25, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) announced today that PDL's board of directors has authorized a new stock repurchase program to acquire up to $25 million of the Company's common stock.  Purchases may be made in open-market transactions, block transactions on or off an exch...
INCLINE VILLAGE, Nev., Sept. 19, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's chief executive officer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York City on Tuesday, September 26, 2017, at 10:20 a.m. EDT. PDL's presentation was originally scheduled...
Page:
...
Next Last
 
= add release to Briefcase